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Background: Surgical scars are crucial cosmetic problem, 
especially when in exposed areas such as the anterior neck 
following thyroidectomy. Objective: To evaluate the impact 
of post-thyroidectomy scars on quality of life (QoL) of thyroid 
cancer patients and identify the relationship between scar 
characteristics and QoL. Methods: Patients with post-thyr-
oidectomy scars on the neck were recruited. QoL was 
measured using the Dermatology Life Quality Index (DLQI). 
Scar characteristics were graded according to Vancouver 
scar scale (VSS) score. Results: Ninety-seven patients com-
pleted a battery of questions at the time of enrollment. 
Post-thyroidectomy scars were classified according to morp-
hology as linear flat scars, linear bulging scars, hypertrophic 
scars or adhesive scars. There were 32 patients (33.0%), 9 
patients (9.3%), 41 patients (42.3%) and 15 patients (15.5%), 
respectively, in each group. The mean total DLQI score was 
9.02. Domain 2 (daily activities, 2.87 points), which includes 
questions about clothing, was the most greatly impacted 
among patients. The total DLQI scores of patients who have 
experienced scar-related symptoms were significantly hig-
her than those of patients without symptoms (p＜0.05). The 
VSS scores were 3.09 for linear flat scars, 6.89 for linear 
bulging scars, 6.29 for hypertrophic scars and 5.60 for 
adhesive scars. However, the DLQI scores did not signi-
ficantly differ among scar types or VSS scores. Conclusion: 
Post-thyroidectomy scars on the neck affect the QoL of 
thyroid cancer patients regardless of scar type. Therefore, 
clinicians should pay attention to the psychological effects of 
scars on patients and take care to minimize post-thyroi-
dectomy scar. (Ann Dermatol 26(6) 693∼699, 2014)
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INTRODUCTION
Thyroid cancer is one of the most rapidly increasing tumor 
types worldwide, including Korea1. Traditional thyroidec-
tomy is the most common method of thyroid cancer 
surgery. In this method, the thyroid is typically ap-
proached through transverse incisions in the neck2. As a 
result, it causes scar formation in a highly visible area of 
the neck.
These visible scars cause significant cosmetic problems, 
leading to functional impairment and psychosocial bur-
dens. Balci et al.3 has reported that the quality of life (QoL) 
of patients with keloid and hypertrophic scars is impaired 
as much as in patients with psoriasis. However, there are 
no studies investigating how much postthyroidectomy 
scarring affects the QoL of thyroid cancer patients relative 
to other types of scars, cancers, or dermatological dis-
orders.
The Dermatology Life Quality Index (DLQI) is a derma-
tology-specific QoL measure that has been widely vali-
dated in a range of skin conditions4,5. It has been used in 
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Table 1. Baseline characteristics of patients (n=97)
Baseline characteristic n (%)
Sex
Male 8 (8.3)
Female 89 (91.8)
Age (yr)
<20 2 (2.1)
20∼39 63 (65.0)
40∼60 30 (30.9)
>60 2 (2.1)
Body mass index
<18.5 14 (14.4)
18.5∼24.9 71 (73.2)
≥25.0 12 (12.4)
Marital status
Married 36 (37.1)
Single 61 (62.9)
Employment status
Yes 54 (55.7)
No 43 (44.3)
Education (yr)
≤9 3 (3.1)
10∼12 18 (18.6)
≥13 76 (78.4)
No. of children
0 47 (48.5)
≥1 50 (51.6)
Cigarette smoking
Yes 6 (6.2)
No 91 (93.8)
Type of scar
Linear flat scar 32 (33.0)
Linear bulging scar 9 (9.3)
Hypertrophic scar 41 (42.3)
Adhesive scar 15 (15.5)
Time elapsed after surgery 
<1 year (active scar) 66 (68.0)
≥1 year (mature scar) 31 (32.0)
Symptoms
None 33 (34.0)
Yes 64 (66.0)
Pruritus 37 (38.1)
Pain 12 (12.4) 
Burning 3 (3.1) 
Tightening 29 (29.9)
Other 2 (2.1)
33 different skin conditions in 32 countries and is 
available in 55 languages. Therefore, the aim of this study 
is to evaluate the impact of postthyroidectomy scars on 
the QoL of thyroid cancer patients and identify the 
relation between scar characteristics and QoL.
MATERIALS AND METHODS
Study design
This single-center, prospective observational study was 
conducted from October 2011 to March 2012 at the 
Department of Dermatology, Gangnam Severance Hos-
pital, Korea. Informed consent was obtained from all 
participants after providing extensive written and oral 
information about the study. The study protocol was 
approved by the ethics committee of Gangnam Severance 
Hospital (Registration No. 3-2011-0193).
Patients
Thyroid cancer patients who underwent traditional thy-
roidectomy surgery at the Department of Surgery in 
Gangnam Severance Hospital, Yonsei University were 
assessed for inclusion. The criteria for patient selection 
were as follows: patients with thyroid cancer who had 
undergone traditional thyroidectomy procedures at least 2 
months before the survey; able to provide written 
informed consent; aged 16 years or older; able to read the 
Korean language; and did not have any severe derma-
tological, mental, or physical illnesses.
Measures
The DLQI is one of the most frequently used QoL measure 
in dermatology6. It consists of 10 questions and is 
designed for use in patients older than 16 years. The 
questions are classified to subscales: symptoms and 
feelings (questions 1 and 2), daily activities (questions 3 
and 4), leisure (questions 5 and 6), personal relationships 
(questions 8 and 9), work and school (question 7), and 
treatment (question 10) (Appendix). The total DLQI score 
is calculated by summing the scores of the 10 questions 
with a maximum score of 30 and a minimum score of 0. 
The higher the score, the more the QoL is impaired. 
Grade 1 (0∼1) indicates no effect, grade 2 (2∼5) indi-
cates a small effect, grade 3 (6∼10) indicates a moderate 
effect, grade 4 (11∼20) indicates a very large effect, and 
grade 5 (21∼30) indicates an extremely large effect.7 In 
this study, we used a validated Korean translation of the 
DLQI.
Photographs of all scars were taken by using identical 
camera settings, patient positioning, and room lighting. 
Two dermatologists blinded to other study parameters 
performed the clinical assessment of scars by using a 
modified Vancouver scar scale (VSS) composed of four par-
ameters: vascularity, thickness, pliability, and pigmentation8. 
To evaluate vascularity more precisely, dermoscopic 
examination was performed. Postthyroidectomy scar 
lesions present for ≤1 year were classified as active scars, 
whereas those present for ＞1 year were classified as 
mature scars.
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Fig. 1. Classification of postthyroid-
ectomy scars. (A) Linear flat scar.
(B) Linear bulging scar. (C) Hyper-
trophic scar. (D) Adhesive scar.
Data analysis
Statistical analyses were performed by using SAS version 
9.2 software (SAS Institute, Cary, NC, USA). Descriptive 
data are presented as counts with percentages and means 
with standard deviations. Logistic regression was used to 
identify relations between DLQI scores and clinical, 
social, and demographic factors. Risk factors with p＜0.05 
were considered statistically significant in a univariate 
model. Results are presented with p-values.
RESULTS
Patient characteristics 
Ninety-seven patients (8 men, 89 women) were recruited 
for the study. The demographic and clinical characteristics 
of the participants are given in Table 1. The median age 
was 36.9 years (range, 16∼64 years). The mean time that 
had elapsed from the thyroidectomy to the survey was 
12.9 months.
The classification and definition of postthyroidectomy 
scars were as follows (Fig. 1): (i) linear flat scars, flat scars 
with linear configuration; (ii) linear bulging scars, similar 
to linear flat scars but with bulging on the upper portion of 
the scar; (iii) hypertrophic scars, elevated scars that are 
typically raised and stiffer than the surrounding skin; and 
(iv) adhesive scars, immovable by manual inspection, and 
exhibiting fixation to the underlying skin.
The postthyroidectomy scars were classified as linear flat 
scars in 32 patients (33.0%), linear bulging scars in 9 
patients (9.3%), hypertrophic scars in 41 patients (42.3%), 
and adhesive scars in 15 patients (15.5%).
Symptoms associated with postthyroidectomy scars were 
present in 64 patients (66.0%), including pruritus (n=37, 
38.1%), tightening (n=29, 29.9%), pain (n=12, 12.4%), 
and burning sensation (n=3, 3.1%). After traditional thyr-
oidectomy, the obtained specimens were diagnosed as 
papillary microcarcinoma in 67 patients (69.1%), papillary 
carcinoma in 24 patients (24.7%), adenomatous hyperpla-
sia in 3 patients (3.1%), follicular adenoma in 2 patients 
(2.1%), and thyroid goiter in 1 patient (1.0%), according 
to postoperative pathological evaluation.
Vancouver scar scale 
The VSS scores differed significantly among the types of 
scars (Table 2, Fig. 2; p＜0.05). The mean VSS score was 
5.18±2.24; the VSS scores were as follows: 3.09 for linear 
flat scars, 6.89 for linear bulging scars, 6.29 for hyper-
trophic scars, and 5.60 for adhesive scars.
Dermatology Life Quality Index scores 
DLQI indicated that postthyroidectomy scars impaired 
QoL in thyroid cancer patients (Table 3). The mean DLQI 
score was 9.02±5.79 (minimum=0, maximum=12). 
Domain 2 (daily activities, 2.87 points) was the most 
greatly affected among patients with postthyroidectomy 
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Table 2. VSS according to scar type
Type of scar n (%) Vancouver scar scale (mean±SD) p-value*
Linear flat scar 32 (33.0) 3.09±1.573 <0.001
Linear bulging scar 9 (9.3) 6.89±1.364
Hypertrophic scar 41 (42.3) 6.29±1.677
Adhesive scar 15 (15.5) 5.60±2.063
VSS: Vancouver scar scale, SD: standard deviation. *ANOVA.
Fig. 2. Vancouver scar scale according to the type of scar.
Table 3. Distribution of subscale and total DLQI scores
DLQI score 
(mean±SD)
Subscale
Symptoms and feeling (items 1 and 2) 1.91±1.17
Daily activities (items 3 and 4) 2.87±1.66
Leisure (items 5 and 6) 1.78±1.63
Personal relationship (items 8 and 9) 0.36±0.63
Work and school (item 7) 1.13±1.29
Treatment (item 10) 0.52±0.84
Total DLQI score 9.02±5.79
DLQI: Dermatology Life Quality Index, SD: standard deviation.
Fig. 3. Mean score of each item of the Dermatology Life Quality 
Index.scars. The lowest mean DLQI individual score was for 
item 7 (work and school, 0.36 points), whereas the highest 
mean DLQI score was for item 4 (clothing, 1.95 points) 
(Fig. 3). The relations between DLQI scores and clinical, 
social, and demographic factors were analyzed by using 
logistic regression analyses (Table 4). A univariate analysis 
showed that patients with associated symptoms such as 
pruritus, pain, burning, or tightening (ratio of mean DLQI 
differences in scores of patients without the symptom to 
patients with the symptom=6.45 : 10.34) showed greater 
QoL impairment. Scores were not associated with age, 
body mass index (BMI), employment, marital status, 
number of children, smoking, type of scar, time elapsed 
after surgery, or VSS score. 
DISCUSSION
The incidence of thyroid cancer has been increasing in 
many countries, including the United States, the United 
Kingdom, France, China, and Korea1,9,10. There has been 
an especially large increase in the incidence rates in 
women (from 2.4 to 4.5 per 100,000 population)10. As the 
incidence of thyroid cancer has increased, the number of 
thyroidectomy surgeries has also increased. Although 
thyroidectomy is usually performed without many compli-
cations by experienced surgeons at most medical centers, 
postthyroidectomy scarring is unavoidable11.
To ameliorate this adverse cosmetic outcome, there have 
been efforts to perform alternative techniques including 
transaxillary or scarless endoscopic thyroidectomy and 
minimally invasive thyroidectomy2,12,13. However, trad-
itional thyroidectomy is still the most common method of 
thyroid surgery because it provides good direct exposure 
to facilitate safe dissection, and is a quick procedure with 
low morbidity and minimal mortality.12
As scarring after traditional thyroidectomy occurs on the 
anterior neck, postthyroidectomy scars are visible and 
exposed. Furthermore, in some patients, we have 
observed that traditional neck incisions could result in 
hypertrophic scar formation (unpublished data). Thus, 
patients with postthyroidectomy scars are likely to have 
decreased QoL.
Decreased QoL is common in patients affected by chronic 
skin disease. The DLQI questionnaire has been used to 
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Table 4. Relations between DLQI scores and disease-related
patient characteristics
Variable Number DLQI (mean±SD)
Univariate 
p-value*
Sex 0.992
Male 8 9.00±6.279
Female 89 9.02±5.784
Age 97 0.379
Body mass index 97 0.328
Marital status 0.794
Married 61 8.90±5.691
Single 36 9.22±6.034
Employment status 0.459
Yes 54 8.63±5.684
No 43 9.51±5.954
Education (yr) 0.406
≤9 3 8.00±5.568
10∼12 18 10.67±6.598
≥13 76 8.67±5.606
No. of children 0.835
0 47 8.89±5.700
≥1 50 0.14±5.932
Cigarette smoking 0.658
Yes 6 8.00±4.427
No 91 9.09±5.883
Type of scar 0.724
Linear flat scar 32 8.66±6.383
Linear bulging scar 9 10.11±4.910
Hypertrophic scar 41 8.61±5.431
Adhesive scar 15 10.27±6.204
Time elapsed after 
the surgery (yr)
0.812
<1 66 8.92±5.581
≥1 31 9.23±6.307
Symptoms 0.001
None 33 6.45±5.093
Yes 64 10.34±5.719
Vancouver scar scale 97 0.769
DLQI: Dermatology Life Quality Index, SD: standard deviation. 
*Univariate regression analysis.
assess the QoL of patients with various dermatologic dis-
eases, such as psoriasis, vitiligo, acne vulgaris, atopic 
dermatitis, and hypertrophic scars. In vitiligo patients, the 
mean DLQI scores ranged from 4.82 to 10.674,14-16; in 
patients with psoriasis and scabies, the mean DLQI scores 
ranged from 8.73 to 9.16 and 10.09, respectively3,5,17. The 
mean DLQI scores of patients with severe atopic 
dermatitis was 8.818. In this study, the mean DLQI score of 
patients with postthyroidectomy scar was 9.02, which is 
comparable to those of psoriasis and severe atopic 
dermatitis18,19.
Balci et al.3 recently compared DLQI scores in patients 
with keloid and hypertrophic scars to those of psoriasis 
patients and normal controls. The average DLQI score of 
patients with postthyroidectomy scars in the present study 
(9.02) is much higher than those of patients with 
hypertrophic and keloid scars (7.79) and normal controls 
(0.58) reported in the previous study, and is even slightly 
higher than that of patients with psoriasis (8.73). Rapp et 
al.20 reported that patients with psoriasis vulgaris exp-
erience the same reductions in QoL as patients with 
life-threatening diseases, such as severe heart failure. 
Therefore, investigations of QoL not only in patients with 
chronic diseases but also in those with postsurgical scars 
are important to appropriately manage such patients.
Moreover, the mean DLQI scores of patients who have 
experienced scar-related symptoms were significantly 
higher than those of patients without symptoms (10.34 : 
6.45 points, p＜0.05). In this study, 66.0% of patients 
(n=64) experienced more than one symptom, including 
pruritus, pain, burning, and tightening. This suggests that 
management and treatment to relieve scar-related symptoms 
is one of the most important aspects in the care of postthy-
roidectomy scars provided by attending physicians.
Interestingly, the DLQI scores of our patients with postthy-
roidectomy scars were not associated with either the 
characteristics of thyroid scars (duration, type, and VSS 
score) or with patient characteristics (age, sex, BMI, marital 
status, employment status, education, and smoking). The 
QoL does not seem to be associated with the severity or 
type of the scar, but rather with the presence of the scar 
itself. One study about the QoL of patients with keloids 
and hypertrophic scars reported similar results to ours3. 
The DLQI scores of patients with keloids and hypertrophic 
scars were not associated with age, sex, and duration of 
disease. Thus, all patients with postthyroidectomy scars 
may be affected by decreased QoL regardless of the 
characteristics of the scar or their own status.
Bock et al.21 reported that the QoL in patients with visible 
scars is poorer than in those with invisible lesions. Thyroid 
scars after traditional thyroidectomy are almost always 
located on the anterior neck. This may explain the higher 
DLQI scores than those of patients with hypertrophic and 
keloid scars.
Our study has some limitations. We classified four types 
of postthyroidectomy scars according to the visible 
morphologic type. However, some scars have mixtures of 
characteristics. Therefore, we classified the patients 
according to the most noticeable feature of the scar. 
Scarring, especially hypertrophic scarring, has a rapid 
growth phase for up to 6 months and then gradually 
regresses22. Scars may change in morphology over time. 
We assessed only a single period during the sequence of 
scarring. In addition, our study included a limited number 
of patients.
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To our knowledge, this is the first attempt to measure QoL 
in patients with postthyroidectomy scars. Our findings 
suggest that the QoL of patients with postthyroidectomy 
scars is impaired after traditional thyroidectomy as much 
as that of patients with other chronic skin diseases, such as 
psoriasis, vitiligo, and severe atopic dermatitis. Future 
studies should explore the improvement of QoL through 
the management of postthyroidectomy scars.
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Appendix. Dermatology Life Quality Index (DLQI) questionnaire in Korean
